EffPha – An expert-based CRO for drug development
廠商名稱:精睿醫藥科技股份有限公司
發佈日期:2024-07-05
攤位號碼:M720
Efficient Pharma Management Corp. (EffPha) is a full-service CRO providing drug development services, including strategic and technical consulting, biostatistics, data management, regulatory dossier preparation and submission, and clinical study management and monitoring.
EffPha has established a team of experts with over 30 years of drug development experience from global pharmaceutical companies since founded. That EffPha is an expert-based CRO is the brand positioning by providing advice based on practical industry experience from domestic and international new drug development companies.
We knew an experienced and talented drug development team can not only provide decision-makers with the best strategies of drug development, advise and direct clinical operations, but also identify potential risks in drug development, which allows them to further plan risk management or adjust the direction of product development. Therefore, it would help shorten drug development timelines and mitigate risks for biotech and pharmaceutical companies, allocating development resources more efficiently.
EffPha excels at proposing the most suitable drug development strategies, designing clinical trials with high success rates, and providing high-quality clinical trial monitoring and management for the purpose of providing clients with the most efficient services. In recent years, clinical trials have tended to be conducted in multiple countries. In response, EffPha has set its sights on the global market. EffPha has taken the initiative to build a global presence, expand CRO services for international multi-center clinical trials, and move forward with our long-term collaborative pharmaceutical partners.
Visit us to learn how EffPha can help support your drug development projects at https://www.effpha.com/.
更多參展商新聞稿
- 生技展亮點活動-報名2024生技展國鼎新藥研討會 國鼎生物科技股份有限公司 / 2024-07-06
- 更多資訊請洽力明官網 力明儀器有限公司 / 2024-07-05
- EffPha meets you at BIO Asia- Taiwan Exhibition 精睿醫藥科技股份有限公司 / 2024-07-05
- 無懼高鹽,更易純化-全能核酸酶 Saltonase 凱杰企業管理(上海)有限公司 / 2024-07-05
- Vega 高通量自動超音波成像系統在台灣正式上市 博克科技股份有限公司 / 2024-07-05
- 永昕生醫與日本CHITOSE聯手締造細胞株開發新紀元 永昕生物醫藥股份有限公司 / 2024-07-04
- 保瑞進軍美國市場再下一城 宣布收購無菌針劑廠 保瑞藥業股份有限公司 / 2024-07-03
- 圖爾思生物科技 | BioLector XT 加速微生物製程與開發效率 圖爾思生物科技股份有限公司 / 2024-07-03
- 禮文公司正式成為Biochemazone™ 台灣官方授權台灣代理 禮文股份有限公司 / 2024-07-03
- 產業領導先驅 牛樟芝業界的專家 台灣利得生物科技股份有限公司 / 2024-07-03
- 日本機能性表示食品申請及市場開拓 綠霖生技有限公司 / 2024-07-03
- 優品速遞: QIAGEN Beverly 一管法酶切建庫 凱杰企業管理(上海)有限公司 / 2024-07-02
- 與 OEM by QIAGEN 成為戰略合作夥伴,有效拓展您的能力 凱杰企業管理(上海)有限公司 / 2024-07-02
- 磁懸浮離心泵和四元隔膜泵對 mRNA 包封 LNPs 影響的比較報告 瑞士商力威磁浮技術有限公司 台灣分公司 / 2024-07-01
- CRISPR cGMP gRNA 製造 每得科技有限公司 / 2024-06-27
- 高通量測序NGS助手—Feyond-F100螢光酵素免疫分析儀 每得科技有限公司 / 2024-06-27
- 每得生命科學解決方案 是您設備換新的助力 每得科技有限公司 / 2024-06-27
- 伊達醫療器材公司以創新、專業、敬業為品質政策,提供最尖端的創新醫療光電醫療器材設備。 伊達醫療器材科技股份有限公司 / 2024-06-25
- 中裕新藥:從研發到市場的全面 CDMO 服務 中裕新藥股份有限公司 / 2024-06-25
- 癌症風險可以算出來? 銳準生醫解密癌蛋白體,全球首創多指標演算法打破早期癌篩極限! 銳準生醫股份有限公司 / 2024-06-21